Skip to main content

Table 5 Viability of FPMSC between thawing and administration under GMP requirements

From: Optimizing mesenchymal stem cell therapy: from isolation to GMP-compliant expansion for clinical application

Sample ID

W455623000032

W455623000038

Viability T0 (> 70%)

96%

96%

Viability T1 (> 70%)

96%

95%

Viability T2 (> 70%)

96%

95%

Viability T3 (> 70%)

97%

96%

Viability T4 (> 70%)

97%

96%

Average (> 70%)

96.4 ± 0.54

95.6 ± 0.54